Search Results - "Jouan, F"

Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer by Ricordel, Charles, Chaillot, L., Vlachavas, E. I., Logotheti, M., Jouannic, A., Desvallees, T., Lecuyer, G., Aubry, M., Kontogianni, G., Mastrokalou, C., Jouan, F., Jarry, U., Corre, R., Le Guen, Y., Guillaudeux, T., Lena, H., Chatziioannou, A., Pedeux, Rémy

“…Circulating tumor cells (CTC) have been studied in various solid tumors but clinical utility of CTC in small cell lung cancer (SCLC) remains unclear. The aim…”
Get full text

Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma? by Dolley-Hitze, T, Jouan, F, Martin, B, Mottier, S, Edeline, J, Moranne, O, Le Pogamp, P, Belaud-Rotureau, M-A, Patard, J-J, Rioux-Leclercq, N, Vigneau, C

“…Background: The growth factor Angiotensin-2 signals through Angiotensin receptor type 1 (AT1-R) in a broad range of cell types and tumours and through the…”
Get full text

All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study by Vigneau, Cécile, Lorcy, Nolwenn, Dolley-Hitze, Thibault, Jouan, Florence, Arlot-Bonnemains, Yannick, Laguerre, Brigitte, Verhoest, Gregory, Goujon, Jean Michel, Belaud-Rotureau, Marc-Antoine, Rioux-Leclercq, Nathalie

“…Specific therapies that target vascular endothelial growth factor (VEGF) and its receptors have improved the survival of patients with metastatic cancers, but…”
Get full text

The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform by Chesnel, F, Hascoet, P, Gagné, J P, Couturier, A, Jouan, F, Poirier, G G, Le Goff, C, Vigneau, C, Danger, Y, Verite, F, Le Goff, X, Arlot-Bonnemains, Y

“…Background: The von Hippel–Lindau ( VHL ) gene encodes two mRNA variants. Variant 1 encodes two protein isoforms, pVHL 213 and pVHL 160 , that have been…”
Get full text

Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma by Patard, J-J, Rioux-Leclercq, N, Masson, D, Zerrouki, S, Jouan, F, Collet, N, Dubourg, C, Lobel, B, Denis, M, Fergelot, P

“…Background: The von Hippel–Lindau gene ( VHL ) alteration, a common event in sporadic clear-cell renal-cell carcinoma (CCRCC), leads to highly vascularised…”
Get full text

Overexpression of the polarity protein PAR‐3 in clear cell renal cell carcinoma is associated with poor prognosis by Dugay, F., Goff, X., Rioux‐Leclerq, N., Chesnel, F., Jouan, F., Henry, C., Cabillic, F., Verhoest, G., Vigneau, C., Arlot‐Bonnemains, Y., Belaud‐Rotureau, MA

“…The partition‐defective 3 (PAR‐3) protein is implicated in the development and maintenance of cell polarity and is associated with proteins that mediate the…”
Get full text

Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage by Rebillard, A, Rioux-Leclercq, N, Muller, C, Bellaud, P, Jouan, F, Meurette, O, Jouan, E, Vernhet, L, Le Quément, C, Carpinteiro, A, Schenck, M, Lagadic-Gossmann, D, Gulbins, E, Dimanche-Boitrel, M T

“…Cisplatin is one of the most effectively used chemotherapeutic agents for cancer treatment. However, in humans, important cytotoxic side effects are observed…”
Get full text

Renin-angiotensin system and urological cancers by Verhoest, G, Dolley-Hitze, T, Jouan, F, Bensalah, K, Arlot-Bonnemains, Y, Dugay, F, Belaud-Rotureau, M-A, Rioux-Leclercq, N, Vigneau, C

“…A controversy animates the literature on the potential role of the renin-angiotensin system (RAS) in tumorogenesis. The objective of this review was to…”
Get more information

The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma by Perrin, C, Patard, J-J, Jouan, F, Collet, N, Théoleyre, S, Edeline, J, Zerrouki, S, Laguerre, B, Bellaud-Roturaud, M-A, Rioux-Leclercq, N, Vigneau, C

“…To determine the prognostic significance of the neutrophil gelatinase-associated lipocalin (NGAL) and the matrix metalloproteinase 9 (MMP-9) in clear cell…”
Get more information

Pneumomédiastin secondaire à une infection de type SRAS-nCOV-2 by Mathurin, M., Ngo, S., Jouan, F., Gambier, N., Lhote, F.

Get full text

Expression of Aurora kinases in clear cell renal carcinoma by Martin, B, Jouan, F, Stock, N, Delcros, J.G, Rioux, N, Patard, J.J, Arlot, J, Fergelot, P

Get full text

P11.61 Development of a novel preclinical GBM model and therapeutic impact of IRE1 inhibition by Le Reste, P, Pineau, R, Jouan, F, Samal, J, Jegou, G, Patterson, J, Vauleon, E, Avril, T, Pandit, A, Chevet, E

“…Abstract Glioblastoma Multiforme (GBM) is the most severe primary brain tumor and represents more than 15% of all brain tumors. Despite an aggressive treatment…”
Get full text

Pneumomédiastin secondaire à une infection de type SRAS-nCOV-2 by Mathurin, M., Ngo, S., Jouan, F., Gambier, N., Lhote, F.

“…Le SRAS-nCOV-2 ou COVID-19 est un nouveau coronavirus identifié le 6 janvier 2020. Les premiers cas ont été rapportés à Wuhan, ville chinoise de la province de…”
Get full text

Overexpression of PD-1 and PD-L1 in renal cell carcinoma is associated with poor prognosis in metastatic patients treated with sunitinib by Brunot, A., Rioux-Leclercq, N., Bensalah, K., Verhoest, G., Edeline, J., Bellaud, P., Viel, R., Jouan, F., Laguerre, B., Kammerer-Jacquet, S.-F.

Get full text

562 ADDITIVE EFFECTS FOR THE ASSOCIATION OF TEMSIROLIMUS WITH EITHER SUNITINIB OR SORAFENIB by Edeline, J, Bigot, P, Martin, B, Jouan, F, Zerrouki, S, Vigneau, C, Mottier, S, Patard, J.J, Rioux-Leclercq, N

Get full text

711 THE PROGNOSIC IMPORTANCE OF ANGIOGENIC PHENOTYPE IN RENAL CELL CARCINOMA by Bigot, P, Edeline, J, Vigneau, C, Martin, B, Jouan, F, Denis, M, Patard, J.J, Rioux-Leclercq, N

Get full text

A 70-Year-Old Woman With Acute Chest Pain and a Paracardiac Mass by Jouan, Fanny, MD, Sacre, Karim, MD, PhD, Debray, Marie-Pierre, MD, Crestani, Bruno, MD, PhD, Chauveheid, Marie-Paule, MD, Papo, Thomas, MD

Get full text

572 PLASMA AND TISSUE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) LEVELS IN RENAL CELL CARCINOMA: A PROSPECTIVE STUDY OF 50 CASES by Rioux-Leclercq, N, Fergelot, P, Zerrouki, S, Jouan, F, Bellaud, P, Patard, J.J

Get full text

Infiltration sclérodermiforme péribuccale : une localisation rare de l’amylose AL by Mahévas, T., Kottler, D., Jouan, F., Deschamps, L., Abrial, Y., Crickx, B., Descamps, V.

“…Les manifestations cutanées liées aux dépôts d’une substance amyloïde AL sont nombreuses et polymorphes. Leur connaissance peut parfois amener les cliniciens à…”
Get full text

Diagnostiquer une maladie systémique chez les patients hospitalisés pour méningite aseptique : une étude observationnelle by Boudot De La Motte, M., Abbas, R., Jouan, F., Van Gysel, D., Chauveheid, M.P., Papo, T., Sacré, K.

“…La méningite aseptique est une complication neurologique possible des maladies systémiques (MS). Si la méningite aseptique est bien décrite dans le cadre…”
Get full text